Taofeek K. Owonikoko, Mohammad S. Hossain, Chandar Bhimani, Zhengjia Chen, Sungjin Kim, Suresh S. Ramalingam, Shi-Yong Sun, Dong M. Shin, Edmund K. Waller and Fadlo R. Khuri Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer Cancer 119
Article first published online: 22 JAN 2013 | DOI: 10.1002/cncr.27937
Disease recurrence remains a major challenge in the management of differentiated thyroid cancer. Serum FAS (tumor necrosis receptor superfamily, member 6) ligand levels demonstrate a significant association with disease recurrence in this patient population.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Copyright © 1999–2013 John Wiley & Sons, Inc. All Rights Reserved.